Genasense® (Oblimersen Sodium), Fludarabine, and Rituximab in Subjects With Chronic Lymphocytic Leukemia
Clinical trial NCT00078234 · COMPLETED
Trial details
- NCT number
- NCT00078234
- Sponsor
- Genta Incorporated
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-11-01
- Primary completion
- 2008-09-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.